7-BROMO-16-METHYL-17,21-BIS(1-OXOPROPOXY)-PREGNA-1,4-DIENE-3,11,20-TRIONE, (7.ALPHA.,16.ALPHA.)-
UNII CJ55NAQ7DC
Substance Identification & Data
This profile provides standardized clinical and technical data for 7-bromo-16-methyl-17,21-bis(1-oxopropoxy)-pregna-1,4-diene-3,11,20-trione, (7.alpha.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CJ55NAQ7DC.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 67212-61-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C28H35BrO7 KVDSCYMKYRFUMT-SHGKFVHUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 7-bromo-16-methyl-17,21-bis(1-oxopropoxy)-pregna-1,4-diene-3,11,20-trione, (7.alpha.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.